BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23084702)

  • 41. Cytotoxicity and topo I targeting activity of substituted 10--nitrogenous heterocyclic aromatic group derivatives of SN-38.
    Li QY; Deng XQ; Zu YG; Lv H; Su L; Yao L; Zhang Y; Li L
    Eur J Med Chem; 2010 Jul; 45(7):3200-6. PubMed ID: 20392545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.
    Sugimori M; Ejima A; Ohsuki S; Uoto K; Mitsui I; Kawato Y; Hirota Y; Sato K; Terasawa H
    J Med Chem; 1998 Jun; 41(13):2308-18. PubMed ID: 9632364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.
    Wang MJ; Liu YQ; Chang LC; Wang CY; Zhao YL; Zhao XB; Qian K; Nan X; Yang L; Yang XM; Hung HY; Yang JS; Kuo DH; Goto M; Morris-Natschke SL; Pan SL; Teng CM; Kuo SC; Wu TS; Wu YC; Lee KH
    J Med Chem; 2014 Jul; 57(14):6008-18. PubMed ID: 25003995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs.
    Lansiaux A; Léonce S; Kraus-Berthier L; Bal-Mahieu C; Mazinghien R; Didier S; David-Cordonnier MH; Hautefaye P; Lavielle G; Bailly C; Hickman JA; Pierré A
    Mol Pharmacol; 2007 Aug; 72(2):311-9. PubMed ID: 17494837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin.
    Yang CJ; Li B; Zhang ZJ; Gao JM; Wang MJ; Zhao XB; Song ZL; Liu YQ; Li H; Chen Y; Lee KH; Morris-Natschke SL; Xu C
    Eur J Med Chem; 2020 Feb; 187():111971. PubMed ID: 31881457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Novel Camptothecin Derivative 3j Inhibits Nsclc Proliferation Via Induction of Cell Cycle Arrest By Topo I-Mediated DNA Damage.
    Liu Y; Zhang J; Feng S; Zhao T; Li Z; Wang L; Wang P; Du H; Yuan S; Sun L
    Anticancer Agents Med Chem; 2019; 19(3):365-374. PubMed ID: 30523769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, Synthesis and Biological Activity of (20S,21S)-7-Cyclohexyl-21-fluorocamptothecin Carbamates as Potential Antitumor Agents.
    Ma H; Chen B; Wang Y; Wang C; Yao J; Zhang W; Miao Z
    Chem Biodivers; 2020 Jul; 17(7):e2000068. PubMed ID: 32342605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Synthesis and antitumor activity of 20-O-linked camptothecin ester derivatives].
    Pan XD; Liu HY; Sun PY; Zhu CG; Yang J; Yuan KH; Han R
    Yao Xue Xue Bao; 2004 Aug; 39(8):591-7. PubMed ID: 15563058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphate ester derivatives of homocamptothecin: synthesis, solution stabilities and antitumor activities.
    Miao Z; Zhang J; You L; Wang J; Sheng C; Yao J; Zhang W; Feng H; Guo W; Zhou L; Liu W; Zhu L; Cheng P; Che X; Wang W; Luo C; Xu Y; Dong G
    Bioorg Med Chem; 2010 May; 18(9):3140-6. PubMed ID: 20371183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors.
    Cincinelli R; Musso L; Artali R; Guglielmi M; Bianchino E; Cardile F; Colelli F; Pisano C; Dallavalle S
    Eur J Med Chem; 2018 Jan; 143():2005-2014. PubMed ID: 29150335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New homocamptothecins: synthesis, antitumor activity, and molecular modeling.
    Miao Z; Sheng C; Zhang W; Ji H; Zhang J; Shao L; You L; Zhang M; Yao J; Che X
    Bioorg Med Chem; 2008 Feb; 16(3):1493-510. PubMed ID: 18207748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.
    Morrell A; Antony S; Kohlhagen G; Pommier Y; Cushman M
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3659-63. PubMed ID: 15203138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. E-ring-modified 7-oxyiminomethyl camptothecins: Synthesis and preliminary in vitro and in vivo biological evaluation.
    Giannini G; Marzi M; Cabri W; Marastoni E; Battistuzzi G; Vesci L; Pisano C; Beretta GL; De Cesare M; Zunino F
    Bioorg Med Chem Lett; 2008 May; 18(9):2910-5. PubMed ID: 18424133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Camptothecin conjugated with DNA minor-groove binder netropsin: enhanced lactone stability, inhibition of human DNA topoisomerase I and antiproliferative activity.
    Sukhanova A; Grokhovsky S; Zhuze A; Devy J; Pluot M; Oleinikov V; Nabiev I
    Anticancer Res; 2003; 23(3B):2609-15. PubMed ID: 12894548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of polyamine architecture on the pharmacological activity of open lactone camptothecin-polyamine conjugates.
    Samorì C; Guerrini A; Varchi G; Beretta GL; Fontana G; Bombardelli E; Carenini N; Zunino F; Bertucci C; Fiori J; Battaglia A
    Bioconjug Chem; 2008 Nov; 19(11):2270-9. PubMed ID: 18839979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
    Fan Y; Weinstein JN; Kohn KW; Shi LM; Pommier Y
    J Med Chem; 1998 Jun; 41(13):2216-26. PubMed ID: 9632354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and cytotoxicity of water soluble quaternary salt derivatives of camptothecin.
    Zu YG; Li QY; Fu YJ; Wang W
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4023-6. PubMed ID: 15225719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural modification of 3-arylisoquinolines to isoindolo[2,1-b]isoquinolinones for the development of novel topoisomerase 1 inhibitors with molecular docking study.
    Van HT; Cho WJ
    Bioorg Med Chem Lett; 2009 May; 19(9):2551-4. PubMed ID: 19328687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular modelling design, synthesis and cytotoxic evaluation of certain substituted 2-(3,4,5-triacetoxybenzoylamino)benzo[d]thiazole and 2-(galloylamino)benzo[d]thiazole derivatives having potential topoisomerase-I inhibitory activity.
    Ismail MA; Tratrat C; Haroun MG
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1331-45. PubMed ID: 22957723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and antitumor activity of aromatic camptothecin esters.
    Cao Z; Mendoza J; Dejesus A; Vardeman D; Giovanella B
    Int J Mol Med; 2008 Apr; 21(4):477-87. PubMed ID: 18360694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.